181 related articles for article (PubMed ID: 27784733)
41. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
Musunuru K; Kathiresan S
Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
[TBL] [Abstract][Full Text] [Related]
42. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
43. Tea Consumption and Longitudinal Change in High-Density Lipoprotein Cholesterol Concentration in Chinese Adults.
Huang S; Li J; Wu Y; Ranjbar S; Xing A; Zhao H; Wang Y; Shearer GC; Bao L; Lichtenstein AH; Wu S; Gao X
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29941658
[TBL] [Abstract][Full Text] [Related]
44. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
45. Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.
Isaacs A; Willems SM; Bos D; Dehghan A; Hofman A; Ikram MA; Uitterlinden AG; Oostra BA; Franco OH; Witteman JC; van Duijn CM
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2233-9. PubMed ID: 23766260
[TBL] [Abstract][Full Text] [Related]
46. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
[TBL] [Abstract][Full Text] [Related]
47. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
[TBL] [Abstract][Full Text] [Related]
48. Identification of 12 novel loci that confer susceptibility to early-onset dyslipidemia.
Yamada Y; Kato K; Oguri M; Horibe H; Fujimaki T; Yasukochi Y; Takeuchi I; Sakuma J
Int J Mol Med; 2019 Jan; 43(1):57-82. PubMed ID: 30365130
[TBL] [Abstract][Full Text] [Related]
49. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
[TBL] [Abstract][Full Text] [Related]
50. A placebo-controlled trial of a proprietary lipid-lowering nutraceutical supplement in the management of dyslipidemia.
Houston M; Rountree R; Lamb J; Phipps S; Meng S; Zhang B
J Biol Regul Homeost Agents; 2016; 30(4):1115-1123. PubMed ID: 28078862
[TBL] [Abstract][Full Text] [Related]
51. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
52. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
[TBL] [Abstract][Full Text] [Related]
53. Gene-environment interaction in dyslipidemia.
Cole CB; Nikpay M; McPherson R
Curr Opin Lipidol; 2015 Apr; 26(2):133-8. PubMed ID: 25692343
[TBL] [Abstract][Full Text] [Related]
54. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
55. Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohort.
de Vries JK; Balder JW; Pena MJ; Denig P; Smit AJ
Atherosclerosis; 2018 Jul; 274():191-198. PubMed ID: 29793176
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
57. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of gene-obesity interaction effects on cholesterol levels: a genetic predisposition score on HDL-cholesterol is modified by obesity.
Lamina C; Forer L; Schönherr S; Kollerits B; Ried JS; Gieger C; Peters A; Wichmann HE; Kronenberg F
Atherosclerosis; 2012 Dec; 225(2):363-9. PubMed ID: 23058813
[TBL] [Abstract][Full Text] [Related]
59. Determination of genetic scores to estimate disturbances in circulating lipid profile biomarkers of adolescents: A preliminary report.
da Mata DL; Coelho ASG; Abdala DSP; Horst MA; Cominetti C
Nutrition; 2021; 91-92():111246. PubMed ID: 34352587
[TBL] [Abstract][Full Text] [Related]
60. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
Chen Y; Du M; Xu J; Chen D
Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
